191 related articles for article (PubMed ID: 32428831)
1. Bromelain-based enzymatic debridement as a treatment of choice in high-risk patient with deep facial burns, a case report.
Ferancikova N; Bukovcan P; Sarkozyova N; Dragunova J; Cucorova V; Koller J
Int J Surg Case Rep; 2020; 71():6-10. PubMed ID: 32428831
[TBL] [Abstract][Full Text] [Related]
2. Enzymatic debridement of deeply burned faces: Healing and early scarring based on tissue preservation compared to traditional surgical debridement.
Schulz A; Fuchs PC; Rothermundt I; Hoffmann A; Rosenberg L; Shoham Y; Oberländer H; Schiefer J
Burns; 2017 Sep; 43(6):1233-1243. PubMed ID: 28363663
[TBL] [Abstract][Full Text] [Related]
3. Enzymatic debridement in critically injured burn patients - Our experience in the intensive care setting and during burn resuscitation.
Bowers C; Randawa A; Sloan B; Anwar U; Phipps A; Muthayya P
Burns; 2022 Jun; 48(4):846-859. PubMed ID: 34493422
[TBL] [Abstract][Full Text] [Related]
4. A Retrospective Review of an Off-label Bromelain-based Selective Enzymatic Debridement (Nexobrid®) in the Treatment of Deep, Partial, and Full Thickness Burns and Hard to Heal Wounds.
Harats M; Haik J; Cleary M; Vashurin I; Aviv U; Kornhaber R
Isr Med Assoc J; 2020 Feb; 22(2):83-88. PubMed ID: 32043324
[TBL] [Abstract][Full Text] [Related]
5. Eschar removal by bromelain based enzymatic debridement (Nexobrid
Hirche C; Citterio A; Hoeksema H; Koller J; Lehner M; Martinez JR; Monstrey S; Murray A; Plock JA; Sander F; Schulz A; Ziegler B; Kneser U
Burns; 2017 Dec; 43(8):1640-1653. PubMed ID: 29033046
[TBL] [Abstract][Full Text] [Related]
6. Enzymatic debridement: past, present, and future.
De Decker I; De Graeve L; Hoeksema H; Monstrey S; Verbelen J; De Coninck P; Vanlerberghe E; Claes KEY
Acta Chir Belg; 2022 Aug; 122(4):279-295. PubMed ID: 35440290
[TBL] [Abstract][Full Text] [Related]
7. Enzymatic debridement of hands with deep burns: a single center experience in the treatment of 52 hands.
Dadras M; Wagner JM; Wallner C; Sogorski A; Sacher M; Harati K; Lehnhardt M; Behr B
J Plast Surg Hand Surg; 2020 Aug; 54(4):220-224. PubMed ID: 32315252
[No Abstract] [Full Text] [Related]
8. Assessing the Effect of Enzymatic Debridement on the Scar Quality in Partial-Thickness Burns to Deep Dermal Burns of the Hand: A Long-Term Evaluation.
Heitzmann W; Schulz A; Fuchs PC; Schiefer JL
Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541207
[No Abstract] [Full Text] [Related]
9. A novel rapid and selective enzymatic debridement agent for burn wound management: a multi-center RCT.
Rosenberg L; Krieger Y; Bogdanov-Berezovski A; Silberstein E; Shoham Y; Singer AJ
Burns; 2014 May; 40(3):466-74. PubMed ID: 24074719
[TBL] [Abstract][Full Text] [Related]
10. Safety of enzymatic debridement in extensive burns larger than 15% total body surface area.
Hofmaenner DA; Steiger P; Schuepbach RA; Klinzing S; Waldner M; Klein H; Enthofer K; Giovanoli P; Mannil L; Buehler PK; Plock JA
Burns; 2021 Jun; 47(4):796-804. PubMed ID: 33143989
[TBL] [Abstract][Full Text] [Related]
11. Preliminary Single-Center Experience of Bromelain-Based Eschar Removal in Children with Mixed Deep Dermal and Full Thickness Burns.
Korzeniowski T; Grywalska E; Strużyna J; Bugaj-Tobiasz M; Surowiecka A; Korona-Głowniak I; Staśkiewicz M; Torres K
J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36013039
[TBL] [Abstract][Full Text] [Related]
12. [Effects of unified surgical scheme for wounds on the treatment outcome of patients with extensive deep burn].
Tang W; Li X; Deng Z; Zhang Z; Zhang X; Zhang T; Zhong X; Chen B; Liu C
Zhonghua Shao Shang Za Zhi; 2015 Aug; 31(4):254-8. PubMed ID: 26715635
[TBL] [Abstract][Full Text] [Related]
13. Historical Perspectives on the Development of Current Standards of Care for Enzymatic Debridement.
Heitzmann W; Fuchs PC; Schiefer JL
Medicina (Kaunas); 2020 Dec; 56(12):. PubMed ID: 33348927
[No Abstract] [Full Text] [Related]
14. Rapid and selective enzymatic debridement of porcine comb burns with bromelain-derived Debrase: acute-phase preservation of noninjured tissue and zone of stasis.
Singer AJ; McClain SA; Taira BR; Rooney J; Steinhauff N; Rosenberg L
J Burn Care Res; 2010; 31(2):304-9. PubMed ID: 20182376
[TBL] [Abstract][Full Text] [Related]
15. Feasibility and safety of enzymatic debridement for the prevention of operative escharotomy in circumferential deep burns of the distal upper extremity.
Fischer S; Haug V; Diehm Y; Rhodius P; Cordts T; Schmidt VJ; Kotsougiani D; Horter J; Kneser U; Hirche C
Surgery; 2019 Jun; 165(6):1100-1105. PubMed ID: 30678870
[TBL] [Abstract][Full Text] [Related]
16. Long-term scar quality after hydrosurgical versus conventional debridement of deep dermal burns (HyCon trial): study protocol for a randomized controlled trial.
Legemate CM; Goei H; Middelkoop E; Oen IMMH; Nijhuis THJ; Kwa KAA; van Zuijlen PPM; Beerthuizen GIJM; Nieuwenhuis MK; van Baar ME; van der Vlies CH
Trials; 2018 Apr; 19(1):239. PubMed ID: 29673408
[TBL] [Abstract][Full Text] [Related]
17. The use of NexoBrid™ enzymatic debridement and coagulation abnormalities.
Capitelli-McMahon H; McCrossan S; Kershaw J; Muthayya P; Anwar MU; Carter A; Sloan B
Burns; 2024 Feb; 50(1):123-131. PubMed ID: 37827936
[TBL] [Abstract][Full Text] [Related]
18. Enzymatic debridement for the treatment of severely burned upper extremities - early single center experiences.
Cordts T; Horter J; Vogelpohl J; Kremer T; Kneser U; Hernekamp JF
BMC Dermatol; 2016 Jun; 16(1):8. PubMed ID: 27342276
[TBL] [Abstract][Full Text] [Related]
19. Bromelain-based enzymatic debridement of e-cigarette burns: a single unit experience.
Ho W; Jones CD; Widdowson D; Bahia H
J Wound Care; 2019 Nov; 28(11):758-761. PubMed ID: 31721672
[TBL] [Abstract][Full Text] [Related]
20. Early experiences using bromelain-based enzymatic debridement in a tertiary burns centre in the United Kingdom: A retrospective case series review.
Arkoulis N; Mabvuure NT; Smith A; Barnes DE
J Plast Reconstr Aesthet Surg; 2021 Jun; 74(6):1402-1407. PubMed ID: 33388270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
